Digital Sensory Phenotyping for Psychiatric Disorders-Journal of Psychiatry and Brain Science-CSCIED科技核心评价数据库-手机版

Digital Sensory Phenotyping for Psychiatric Disorders

Digital Sensory Phenotyping for Psychiatric Disorders

ES评分 0 浏览量：643 下载量：0

DOI	10.20900/jpbs.20200015
刊名	Journal of Psychiatry and Brain Science JPBS
年，卷(期)	2020, 5(3)
作者	Jiacheng Dai,Yu Chen,Cuihua Xia,Jiaqi Zhou,Chunyu Liu*,Chao Chen,
作者单位	Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China ;
Abstract	Today’s genome-wide association studies (GWAS) of psychiatric disorders require massive sample sizes and the identification of biologically relevant phenotypes. Sensory phenotypes, assessed by measuring sensorial function, represent early symptoms of psychiatric disorders, and may involve neurobiological pathways in psychiatric disorders. Yet, sensory phenotypes have rarely been studied in large populations for early diagnosis or GWAS. The concept of using digital devices to collect data on disease-related phenotypes is beginning to attract considerable attention. Is it possible to assess sensory phenotypes dynamically by digital devices? And furthermore, is it possible to explain the pathology of psychiatric disorders through those assessments? In this review, we summarize studies investigating sensory phenotypes and digital phenotyping of psychiatric disorders. We discuss the feasibility of digital phenotyping to better capture disease-related sensory phenotypes. We also discussed potential ethical and privacy issues, which require regulation of governments and collaborations of all researchers to solve. While the emergence of digital phenotyping makes the large-scale and moment-by-moment quantification of sensory phenotypes in psychiatric disorders highly scalable, it also introduces tremendous opportunities for genetic research and health improvement.
KeyWord	psychiatric; phenotype; sensory phenotype; digital phenotyping
基金项目
页码	-

参考文献
相关文献

1.Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychol Med. 2007;37(2):163-80.

2.Kanes S, Tokarczyk J, Chinitz J, Turetsky B, Moberg P, Bucan M, et al. Olfaction: towards a novel mouse endophenotypic model of schizophrenia. Schizophr Res. 2003;1(60):109.

3.Bedwell JS, Brown JM, Miller LS. The magnocellular visual system and schizophrenia: what can the color red tell us? Schizophr Res. 2003;63(3):273-84.

4.Kathmann N, Hochrein A, Uwer R, Bondy B. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. Am J Psychiatry. 2003;160(4):696-702.

5.Wells HRR, Freidin MB, Zainul Abidin FN, Payton A, Dawes P, Munro KJ, et al. GWAS Identifies 44 Independent Associated Genomic Loci for Self-Reported Adult Hearing Difficulty in UK Biobank. Am J Hum Genet. 2019;105(4):788-802.

6.Torous J, Keshavan M. A new window into psychosis: The rise digital phenotyping, smartphone assessment, and mobile monitoring. Schizophr Res. 2018;197:67-8.

7.Torous J, Firth J, Mueller N, Onnela JP, Baker JT. Methodology and Reporting of Mobile Heath and Smartphone Application Studies for Schizophrenia. Harv Rev Psychiatry. 2017;25(3):146-54.

8.Onnela JP, Rauch SL. Harnessing Smartphone-Based Digital Phenotyping to Enhance Behavioral and Mental Health. Neuropsychopharmacology. 2016;41(7):1691-6.

9.Ferreri F, Bourla A, Mouchabac S, Karila L. e-Addictology: An Overview of New Technologies for Assessing and Intervening in Addictive Behaviors. Front Psychiatry. 2018;9:51.

10.Jain SH, Powers BW, Hawkins JB, Brownstein JS. The digital phenotype. Nat Biotechnol. 2015;33(5):462-3.

11.Huckvale K, Venkatesh S, Christensen HJNDM. Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety. NPJ Digit Med. 2019;2(1):1-11.

12.Melnik A, Hairston WD, Ferris DP, Konig P. EEG correlates of sensorimotor processing: independent components involved in sensory and motor processing. Sci Rep. 2017;7(1):4461.

13.Reitan RM, Wolfson D. The significance of sensory-motor functions as indicators of brain dysfunction in children. Arch Clin Neuropsychol. 2003;18(1):11-8.

14.Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126.

15.Wing L, Gould J, Gillberg C. Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV? Res Dev Disabil. 2011;32(2):768-73.

16.Fisch GS. Whither the genotype-phenotype relationship? An historical and methodological appraisal. Am J Med Genet C. 2017;175(3):343-53.

17.Geschwind DH. Genetics of autism spectrum disorders. Trends Cogn Sci. 2011;15(9):409-16.

18.Howlin P. Autism Spectrum Disorders D.G. Amaral, G. Dawson & D.H. Geschwind New York: Oxford University Press, 2011. pp. 1446, £150.00 (hb). ISBN: 978-19-537182-6. Child Adolesc Ment Health. 2012;17(4):256.

19.Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA, et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. Am J Hum Genet. 2017;101(1):5-22.

20.Gottesman, II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160(4):636-45.

21.Glahn DC, Knowles EE, McKay DR, Sprooten E, Raventos H, Blangero J, et al. Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics. Am J Med Genet B. 2014;165b(2):122-30.

22.Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 2001;156(2-3):234-58.

23.Braff DL, Freedman R. Endophenotypes in studies of the genetics of schizophrenia. In Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia (US): Williams and Wilkins; 2002. p. 703-16.

24.Greenwood TA, Shutes-David A, Tsuang DW. Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms. J Psychiatr Brain Sci. 2019;4(2):e190005. doi: 10.20900/jpbs.20190005

25.Braff DL, Tamminga CA. Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesmanʼs Dynamic Legacy. Schizophr Bull. 2017;43(1):10-6.

26.Myles-Worsley M. P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate. Am J Psychiatry. 2002;159(12):2007-12.

27.Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull. 2007;33(1):21-32.

28.Siegel C, Waldo M, Mizner G, Adler LE, Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatry. 1984;41(6):607-12.

29.Clementz BA, Geyer MA, Braff DL. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry. 1998;155(12):1691-4.

30.Clementz BA, Geyer MA, Braff DL. P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol Psychiatry. 1997;41(10):1035-44.

31.Clementz BA, Geyer MA, Braff DL. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res. 1998;30(1):71-80.

32.Judd LL, McAdams L, Budnick B, Braff DL. Sensory gating deficits in schizophrenia: new results. Am J Psychiatry. 1992;149(4):488-93.

33.Waldo MC, Adler LE, Freedman R. Defects in auditory sensory gating and their apparent compensation in relatives of schizophrenics. Schizophr Res. 1988;1(1):19-24.

34.Leonard S, Freedman R. Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry. 2006;60(2):115-22.

35.Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry. 2006;63(6):630-8.

36.Gershon ES, Pearlson G, Keshavan MS, Tamminga C, Clementz B, Buckley PF, et al. Genetic analysis of deep phenotyping projects in common disorders. Schizophr Res. 2018;195:51-7.

37.Chen C, Gershon ES, ediors. Special Issue “Deep Phenotyping of Psychiatric Diseases”
[special issue]. J Psychiatry Brain Sci. 2018. Available from: https://jpbs.hapres.com/SpecialIssuesDPPD.aspx. Accessed 2020 Jun 28.

38.Tamminga CA, Ivleva EI, Keshavan MS, Pearlson GD, Clementz BA, Witte B, et al. Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry. 2013;170(11):1263-74.

39.Bearden CE, Thompson PM. Emerging Global Initiatives in Neurogenetics: The Enhancing Neuroimaging Genetics through Meta-analysis (ENIGMA) Consortium. Neuron. 2017;94(2):232-6.

40.Brewer WJ, Pantelis C, Anderson V, Velakoulis D, Singh B, Copolov DL, et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry. 2001;158(1):107-15.

41.Moberg PJ, Kamath V, Marchetto DM, Calkins ME, Doty RL, Hahn CG, et al. Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull. 2014;40(1):50-9.

42.Baranek GT, David FJ, Poe MD, Stone WL, Watson LR. Sensory Experiences Questionnaire: discriminating sensory features in young children with autism, developmental delays, and typical development. J Child Psychol Psychiatry. 2006;47(6):591-601.

43.Ben-Sasson A, Cermak SA, Orsmond GI, Tager-Flusberg H, Carter AS, Kadlec MB, et al. Extreme sensory modulation behaviors in toddlers with autism spectrum disorders. Am J Occup Ther. 2007;61(5):584-92.

44.Liss M, Saulnier C, Fein D, Kinsbourne M. Sensory and attention abnormalities in autistic spectrum disorders. Autism. 2006;10(2):155-72.

45.Green SA, Hernandez L, Bookheimer SY, Dapretto M. Reduced modulation of thalamocortical connectivity during exposure to sensory stimuli in ASD. Autism Res. 2017;10(5):801-9.

46.Lencer R, Sprenger A, Reilly JL, McDowell JE, Rubin LH, Badner JA, et al. Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study. Schizophr Res. 2015;169(1-3):326-33.

47.Velly AM, Mohit S. Epidemiology of pain and relation to psychiatric disorders. Prog Neuropsychopharmacol Biol psychiatry. 2018;87(Pt B):159-67.

48.Sheng J, Liu S, Wang Y, Cui R, Zhang X. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plast. 2017;2017:9724371.

49.Meerwijk EL, Ford JM, Weiss SJ. Brain regions associated with psychological pain: implications for a neural network and its relationship to physical pain. Brain Imaging Behav. 2013;7(1):1-14.

50.Carter O, Bennett D, Nash T, Arnold S, Brown L, Cai RY, et al. Sensory integration deficits support a dimensional view of psychosis and are not limited to schizophrenia. Transl Psychiatry. 2017;7(5):e1118.

51.Quednow BB, Brinkmeyer J, Mobascher A, Nothnagel M, Musso F, Grunder G, et al. Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci U S A. 2012;109(16):6271-6.

52.Ethridge LE, Hamm JP, Pearlson GD, Tamminga CA, Sweeney JA, Keshavan MS, et al. Event-related potential and time-frequency endophenotypes for schizophrenia and psychotic bipolar disorder. Biol Psychiatry. 2015;77(2):127-36.

53.Enoch MA, White KV, Waheed J, Goldman D. Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depress Anxiety. 2008;25(5):383-92.

54.Moberg PJ, Li M, Kanes SJ, Gur RE, Kamath V, Turetsky BI. Association of schizophrenia with the phenylthiocarbamide taste receptor haplotype on chromosome 7q. Psychiatr Genet. 2012;22(6):286-9.

55.Compton MT, Ionescu DF, Broussard B, Cristofaro SL, Johnson S, Haggard PJ, et al. An examination of associations between the inability to taste phenylthiocarbamide (PTC) and clinical characteristics and trait markers in first-episode, nonaffective psychotic disorders. Psychiatry Res. 2013;209(1):27-31.

56.Brewer WJ, Wood SJ, McGorry PD, Francey SM, Phillips LJ, Yung AR, et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry. 2003;160(10):1790-4.

57.Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 1987;18(5):597-600.

58.Guclu B, Tanidir C, Canayaz E, Guner B, Ipek Toz H, Uneri OS, et al. Tactile processing in children and adolescents with obsessive-compulsive disorder. Somatosens Mot Res. 2015;32(3):163-71.

59.Thornton-Wells TA, Cannistraci CJ, Anderson AW, Kim CY, Eapen M, Gore JC, et al. Auditory attraction: activation of visual cortex by music and sound in Williams syndrome. Am J Intellect Dev Disabil. 2010;115(2):172-89.

60.Bertelsen B, Oranje B, Melchior L, Fagerlund B, Werge TM, Mikkelsen JD, et al. Association Study of CHRNA7 Promoter Variants with Sensory and Sensorimotor Gating in Schizophrenia Patients and Healthy Controls: A Danish Case-Control Study. Neuromol Med. 2015;17(4):423-30.

61.Cabranes JA, Ancin I, Santos JL, Sanchez-Morla E, Garcia-Jimenez MA, Lopez-Ibor JJ, et al. No effect of polymorphisms in the non-duplicated region of the CHRNA7 gene on sensory gating P50 ratios in patients with schizophrenia and bipolar disorder. Psychiatry Res. 2013;205(3):276-8.

62.Garcia-Blanco A, Salmeron L, Perea M. Inhibitory Control for Emotional and Neutral Scenes in Competition: An Eye-Tracking Study in Bipolar Disorder. Biol Psychol. 2017;127:82-8.

63.Hall MH, Schulze K, Sham P, Kalidindi S, McDonald C, Bramon E, et al. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: a combined twin and family study. Am J Med Genet B. 2008;147b(5):619-27.

64.Hamm JP, Ethridge LE, Boutros NN, Keshavan MS, Sweeney JA, Pearlson GD, et al. Diagnostic specificity and familiality of early versus late evoked potentials to auditory paired stimuli across the schizophrenia-bipolar psychosis spectrum. Psychophysiology. 2014;51(4):348-57.

65.Bylsma FW, Moberg PJ, Doty RL, Brandt J. Odor identification in Huntington's disease patients and asymptomatic gene carriers. J Neuropsychiatry Clin Neurosci. 1997;9(4):598-600.

66.Bachmann S, Weisbrod M, Rohrig M, Schroder J, Thomas C, Scherg M, et al. MEG does not reveal impaired sensory gating in first-episode schizophrenia. Schizophr Res. 2010;121(1-3):131-8.

67.Bortolon C, Capdevielle D, Salesse RN, Raffard S. Self-Face Recognition in Schizophrenia: An Eye-Tracking Study. Front Hum Neurosci. 2016;10:3.

68.Brewer WJ, Lin A, Moberg PJ, Smutzer G, Nelson B, Yung AR, et al. Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker. Psychiatry Res. 2012;199(1):8-11.

69.Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, et al. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry. 2008;64(5):376-84.

70.Crespo-Facorro B, Paradiso S, Andreasen NC, OʼLeary DS, Watkins GL, Ponto LL, et al. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. JAMA. 2001;286(4):427-35.

71.Erwin RJ, Turetsky BI, Moberg P, Gur RC, Gur RE. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr Res. 1998;33(3):157-67.

72.Hazlett EA, Rothstein EG, Ferreira R, Silverman JM, Siever LJ, Olincy A. Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia. Schizophr Res. 2015;161(2-3):283-90.

73.Hermens DF, Ward PB, Hodge MA, Kaur M, Naismith SL, Hickie IB. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(6):822-9.

74.Keri S, Beniczky S, Kelemen O. Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia. Am J Psychiatry. 2010;167(4):444-50.

75.Kopala LC, Good KP, Torrey EF, Honer WG. Olfactory function in monozygotic twins discordant for schizophrenia. Am J Psychiatry. 1998;155(1):134-6.

76.Kopala LC, Good KP, Morrison K, Bassett AS, Alda M, Honer WG. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry. 2001;158(8):1286-90.

77.Lang CJ, Schwandner K, Hecht M. Do patients with motor neuron disease suffer from disorders of taste or smell? Amyotroph Lateral Scler. 2011;12(5):368-71.

78.Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res. 2015;163(1-3):63-72.

79.Malaspina D, Coleman E, Goetz RR, Harkavy-Friedman J, Corcoran C, Amador X, et al. Odor identification, eye tracking and deficit syndrome schizophrenia. Biol Psychiatry. 2002;51(10):809-15.

80.Martin LF, Leonard S, Hall MH, Tregellas JR, Freedman R, Olincy A. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am J Med Genet B. 2007;144b(5):611-4.

81.Moberg PJ, Arnold SE, Doty RL, Kohler C, Kanes S, Seigel S, et al. Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry. 2003;160(10):1784-9.

82.Moberg PJ, Roalf DR, Balderston CC, Kanes SJ, Gur RE, Turetsky BI. Phenylthiocarbamide perception in patients with schizophrenia and first-degree family members. Am J Psychiatry. 2005;162(4):788-90.

83.Moberg PJ, Arnold SE, Doty RL, Gur RE, Balderston CC, Roalf DR, et al. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. J Clin Exp Neuropsychol. 2006;28(8):1444-61.

84.Moberg PJ, Arnold SE, Roalf DR, Balderston CC, Abbazia J, Kohler CG, et al. Apolipoprotein E genotype and odor identification in schizophrenia. J Neuropsychiatry Clin Neurosci. 2006;18(2):231-3.

85.Moberg PJ, McGue C, Kanes SJ, Roalf DR, Balderston CC, Gur RE, et al. Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance. Schizophr Res. 2007;90(1-3):221-8.

86.Myles-Worsley M, Ord L, Blailes F, Ngiralmau H, Freedman R. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol Psychiatry. 2004;55(7):663-7.

87.Phillips ML, David AS. Visual scan paths are abnormal in deluded schizophrenics. Neuropsychologia. 1997;35(1):99-105.

88.Plailly J, d'Amato T, Saoud M, Royet JP. Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments. NeuroImage. 2006;29(1):302-13.

89.Roalf DR, Turetsky BI, Owzar K, Balderston CC, Johnson SC, Brensinger CM, et al. Unirhinal olfactory function in schizophrenia patients and first-degree relatives. J Neuropsychiatry Clin Neurosci. 2006;18(3):389-96.

90.Roux P, Brunet-Gouet E, Passerieux C, Ramus F. Eye-tracking reveals a slowdown of social context processing during intention attribution in patients with schizophrenia. J Psychiatry Neurosci. 2016;41(2):E13-21.

91.Rupp CI, Fleischhacker WW, Kemmler G, Kremser C, Bilder RM, Mechtcheriakov S, et al. Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophrenia. Schizophr Res. 2005;74(2-3):149-61.

92.Schneider F, Habel U, Reske M, Toni I, Falkai P, Shah NJ. Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Res. 2007;155(2):103-12.

93.Thoma RJ, Hanlon FM, Moses SN, Ricker D, Huang M, Edgar C, et al. M50 sensory gating predicts negative symptoms in schizophrenia. Schizophr Res. 2005;73(2-3):311-8.

94.Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. JAMA Psychiatry. 2017;74(1):37-46.

95.Turetsky BI, Moberg PJ, Yousem DM, Doty RL, Arnold SE, Gur RE. Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry. 2000;157(5):828-30.

96.Turetsky BI, Moberg PJ, Owzar K, Johnson SC, Doty RL, Gur RE. Physiologic impairment of olfactory stimulus processing in schizophrenia. Biol Psychiatry. 2003;53(5):403-11.

97.Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry. 2003;60(12):1193-200.

98.Turetsky BI, Moberg PJ, Arnold SE, Doty RL, Gur RE. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry. 2003;160(4):703-8.

99.Turetsky BI, Hahn CG, Arnold SE, Moberg PJ. Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology. 2009;34(3):767-74.

100.Ugur T, Weisbrod M, Franzek E, Pfuller U, Sauer H. Olfactory impairment in monozygotic twins discordant for schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2005;255(2):94-8.

101.Kohler CG, Moberg PJ, Gur RE, O’Connor MJ, Sperling MR, Doty RL. Olfactory dysfunction in schizophrenia and temporal lobe epilepsy. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(2):83-8.

102.Boutros N, Zouridakis G, Rustin T, Peabody C, Warner D. The P50 component of the auditory evoked potential and subtypes of schizophrenia. Psychiatry Res. 1993;47(3):243-54.

103.Dong J, Wyss A, Yang J, Price TR, Nicolas A, Nalls M, et al. Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans. Mol Neurobiol. 2017;54(10):8021-32.

104.Dong J, Yang J, Tranah G, Franceschini N, Parimi N, Alkorta-Aranburu G, et al. Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults. Medicine. 2015;94(47):e1892.

105.Kikuchi M, Miura K, Morita K, Yamamori H, Fujimoto M, Ikeda M, et al. Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia. Sci Rep. 2018;8(1):12347.

106.Ma Y, Li J, Yu H, Wang L, Lu T, Pan C, et al. Association of chromosome 5q21.3 polymorphisms with the exploratory eye movement dysfunction in schizophrenia. Sci Rep. 2015;5:10299.

107.Qiu L, Tian L, Pan C, Zhu R, Liu Q, Yan J, et al. Neuroanatomical circuitry associated with exploratory eye movement in schizophrenia: a voxel-based morphometric study. PLoS One. 2011;6(10):e25805.

108.Arnau-Soler A, Macdonald-Dunlop E, Adams MJ, Clarke TK, MacIntyre DJ, Milburn K, et al. Genome-wide by environment interaction studies of depressive symptoms and psychosocial stress in UK Biobank and Generation Scotland. Transl Psychiatry. 2019;9(1):14.

109.Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-7.

110.Doty RL, Frye RE, Agrawal U. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percep Psychophys. 1989;45(5):381-4.

111.Lawton M, Hu MT, Baig F, Ruffmann C, Barron E, Swallow DM, et al. Equating scores of the University of Pennsylvania Smell Identification Test and Sniffinʼ Sticks test in patients with Parkinsonʼs disease. Parkinsonism Relat Disord. 2016;33:96-101.

112.Luck SJ. An introduction to the event-related potential technique. Cambridge (US): MIT press; 2014.

113.Sur S, Sinha VK. Event-related potential: An overview. Ind Psychiatry J. 2009;18(1):70-3.

114.Mutanen TP, Metsomaa J, Liljander S, Ilmoniemi RJ. Automatic and robust noise suppression in EEG and MEG: The SOUND algorithm. NeuroImage. 2018;166:135-51.

115.Insel TR. Digital Phenotyping: Technology for a New Science of Behavior. JAMA. 2017;318(13):1215-6.

116.Torous J, Friedman R, Keshavan M. Smartphone ownership and interest in mobile applications to monitor symptoms of mental health conditions. JMIR mHealth uHealth. 2014;2(1):e2.

117.Bidargaddi N, Musiat P, Makinen VP, Ermes M, Schrader G, Licinio J. Digital footprints: facilitating large-scale environmental psychiatric research in naturalistic settings through data from everyday technologies. Mol Psychiatry. 2017;22(2):164-9.

118.Csikszentmihalyi M, Larson R. Validity and reliability of the Experience-Sampling Method. J Nerv Ment Dis. 1987;175(9):526-36.

119.Litt MD, Cooney NL, Morse P. Ecological momentary assessment (EMA) with treated alcoholics: methodological problems and potential solutions. Health Psychol. 1998;17(1):48-52.

120.Staples P, Torous J, Barnett I, Carlson K, Sandoval L, Keshavan M, et al. A comparison of passive and active estimates of sleep in a cohort with schizophrenia. NPJ Schizophr. 2017;3(1):37.

121.Dickerson RF, Gorlin EI, Stankovic JA, editors. Empath: a continuous remote emotional health monitoring system for depressive illness. In: Proceedings of the 2nd Conference on Wireless Health; 2011 October 10-13; San Diego, USA.

122.McIntyre G, Göcke R, Hyett M, Green M, Breakspear M, editors. An approach for automatically measuring facial activity in depressed subjects. Presented at 2009 3rd International Conference on Affective Computing and Intelligent Interaction and Workshops; 2009 Sep 10-12; Amsterdam, The Netherlands.

123.Saeb S, Lattie EG, Schueller SM, Kording KP, Mohr DC. The relationship between mobile phone location sensor data and depressive symptom severity. PeerJ. 2016;4:e2537.

124.Jacobson NC, Weingarden H, Wilhelm S. Using Digital Phenotyping to Accurately Detect Depression Severity. J Nerv Ment Dis. 2019;207(10):893-6.

125.Beiwinkel T, Kindermann S, Maier A, Kerl C, Moock J, Barbian G, et al. Using Smartphones to Monitor Bipolar Disorder Symptoms: A Pilot Study. JMIR Ment Health. 2016;3(1):e2.

126.Gruenerbl A, Osmani V, Bahle G, Carrasco JC, Oehler S, Mayora O, et al., editors. Using smart phone mobility traces for the diagnosis of depressive and manic episodes in bipolar patients. In: Proceedings of the 5th Augmented Human International Conference; 2014 Mar 7-9; Kobe, Japan.

127.Barnett I, Torous J, Staples P, Sandoval L, Keshavan M, Onnela JP. Relapse prediction in schizophrenia through digital phenotyping: a pilot study. Neuropsychopharmacology. 2018;43(8):1660-6.

128.Minassian A, Henry BL, Geyer MA, Paulus MP, Young JW, Perry W. The quantitative assessment of motor activity in mania and schizophrenia. J Affect Disord. 2010;120(1-3):200-6.

129.Hswen Y, Naslund JA, Brownstein JS, Hawkins JB. Online Communication about Depression and Anxiety among Twitter Users with Schizophrenia: Preliminary Findings to Inform a Digital Phenotype Using Social Media. Psychiatr Q. 2018;89(3):569-80.

130.van der Wee NJA, Bilderbeck AC, Cabello M, Ayuso-Mateos JL, Saris IMJ, Giltay EJ, et al. Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer's disease. Neurosci Biobehav Rev. 2019;97:38-46.

131.Bedi G, Carrillo F, Cecchi GA, Slezak DF, Sigman M, Mota NB, et al. Automated analysis of free speech predicts psychosis onset in high-risk youths. NPJ Schizophr. 2015;1:15030.

132.Gunn JF III, Lester D. Using google searches on the internet to monitor suicidal behavior. J Affect Disord. 2013;148(2-3):411-2.

133.Adhikari S, Stark DE. Video-based eye tracking for neuropsychiatric assessment. Ann N Y Acad Sci. 2017;1387(1):145-52.

134.Koppe G, Guloksuz S, Reininghaus U, Durstewitz D. Recurrent Neural Networks in Mobile Sampling and Intervention. Schizophr Bull. 2019;45(2):272-6.

135.Torous J, Kiang MV, Lorme J, Onnela JP. New Tools for New Research in Psychiatry: A Scalable and Customizable Platform to Empower Data Driven Smartphone Research. JMIR Ment Health. 2016;3(2):e16.

136.Rono HK, Bastawrous A, Macleod D, Wanjala E, Di Tanna GL, Weiss HA, et al. Smartphone-based screening for visual impairment in Kenyan school children: a cluster randomised controlled trial. Lancet Glob Health. 2018;6(8):e924-32.

137.Zhao L, Stinnett SS, Prakalapakorn SG. Visual Acuity Assessment and Vision Screening Using a Novel Smartphone Application. J Pediatr. 2019;213:203-10.e1.

138.Toh WL, Thomas N, Rossell SL. Auditory verbal hallucinations in bipolar disorder (BD) and major depressive disorder (MDD): A systematic review. J Affect Disord. 2015;184:18-28.

139.Krafka K, Khosla A, Kellnhofer P, Kannan H, Bhandarkar S, Matusik W, et al., editors. Eye tracking for everyone. In: Proceedings of the IEEE conference on computer vision and pattern recognition; 2016 Jun 27-30; Las Vegas, USA.

140.Strobl MA, Lipsmeier F, Demenescu LR, Gossens C, Lindemann M, De Vos M. Look me in the eye: evaluating the accuracy of smartphone-based eye tracking for potential application in autism spectrum disorder research. Biomed Eng Online. 2019;18(1):51.

141.Lai H-Y, Saavedra-Pena G, Sodini CG, Sze V, Heldt T. Measuring Saccade Latency using Smartphone Cameras. IEEE J Biomed Health Inform. 2019;24:3:885-97.

142.Teki S, Kumar S, Griffiths TD. Large-Scale Analysis of Auditory Segregation Behavior Crowdsourced via a Smartphone App. PLoS One. 2016;11(4):e0153916.

143.De Sousa KC, Swanepoel DW, Moore DR, Smits C. A smartphone national hearing test: Performance and characteristics of users. Am J Audiol. 2018;27(3S):448-54.

144.Barczik J, Serpanos YC. Accuracy of smartphone self-hearing test applications across frequencies and earphone styles in adults. Am J Audiol. 2018;27(4):570-80.

145.Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14(5):365-76.

146.Denny JC, Bastarache L, Roden DM. Phenome-Wide Association Studies as a Tool to Advance Precision Medicine. Ann Rev Genom Hum Genet. 2016;17:353-73.

147.Smoller JW. The use of electronic health records for psychiatric phenotyping and genomics. Am J Med Genet B. 2018;177(7):601-12.

148.Grindrod K, Boersema J, Waked K, Smith V, Yang J, Gebotys C. Locking it down: The privacy and security of mobile medication apps. Can Pharm J. 2017;150(1):60-6.

149.Huckvale K, Torous J, Larsen ME. Assessment of the Data Sharing and Privacy Practices of Smartphone Apps for Depression and Smoking Cessation. JAMA Netw Open. 2019;2(4):e192542.

150.Barnett S, Huckvale K, Christensen H, Venkatesh S, Mouzakis

引用本文

Jiacheng Dai,Yu Chen,Cuihua Xia,Jiaqi Zhou,Chunyu Liu*,Chao Chen. Digital Sensory Phenotyping for Psychiatric Disorders, Journal of Psychiatry and Brain Science. 2020; 5; (3). https://doi.org/10.20900/jpbs.20200015.

文献评论

相关学者

相关机构